Viridian Therapeutics Shares Are Trading Higher After BTIG Raised Its Price Target on the Stock From $56 to $61.
Viridian Therapeutics Shares Are Trading Higher After BTIG Raised Its Price Target on the Stock From $56 to $61.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.